Cleared Traditional

K202335 - Ambra ProViewer

K202335 is the FDA 510(k) clearance for Ambra ProViewer by Dicom Grid Inc Dba Ambra Health. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 18-day FDA review.

K202335 · Dicom Grid Inc Dba Ambra Health · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
18d
Days
Class 2
Risk

K202335 is an FDA 510(k) clearance for the Ambra ProViewer. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Dicom Grid Inc Dba Ambra Health (New York, US). The FDA issued a Cleared decision on September 4, 2020 after a review of 18 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Dicom Grid Inc Dba Ambra Health devices

Submission Details

510(k) Number K202335 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 17, 2020
Decision Date September 04, 2020
Days to Decision 18 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d faster than avg
Panel avg: 107d · This submission: 18d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Accelerated Device Approval Services
Rafael Aguila

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K202335.
Aline Ablation Intelligence
K202297 · Mirada Medical, Ltd. · Sep 2020
AcroDTI Visualizer
K201948 · Acroviz, Inc. · Sep 2020
3Shape Implant Studio
K202256 · 3Shape Medical A/S · Sep 2020
Synapse 3D Cardiac Tools
K200973 · Fujifilm Corporaton · Aug 2020
AVIEW
K200714 · Coreline Soft Co., Ltd. · Aug 2020
EzDent-i/ E2/ Prora View/ Smart M Viewer
K202116 · Ewoosoft Co., Ltd. · Aug 2020